Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37,253,000
-
Total 13F shares
-
24,585,574
-
Share change
-
+61,568
-
Total reported value
-
$297,276,117
-
Put/Call ratio
-
825%
-
Price per share
-
$12.12
-
Number of holders
-
110
-
Value change
-
+$746,270
-
Number of buys
-
5
-
Number of sells
-
1
Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q4 2013
As of 31 Dec 2013,
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) was held by
110 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,585,574 shares.
The largest 10 holders included
GUGGENHEIM CAPITAL LLC, Opus Capital Group, LLC, DIMENSIONAL FUND ADVISORS LP, ARIEL INVESTMENTS, LLC, WYNNEFIELD CAPITAL INC, KILLEN GROUP INC, BlackRock Institutional Trust Company, N.A., ROYAL BANK OF CANADA, VANGUARD GROUP INC, and BlackRock Fund Advisors.
This page lists
110
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.